Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Åke Borg(Lund University), Volker Arndt(German Cancer Research Center), Michael Lush(University of Cambridge), Jonathan P. Tyrer(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Banu Arun(The University of Texas Health Science Center at Houston), Amie Blanco(University of California, San Francisco), Xia Jiang(Xuzhou Medical College), Mahdi Moradi Marjaneh(NIHR Imperial Biomedical Research Centre), William J. Blot(Shanghai Cancer Institute), Joe Dennis(University of Cambridge), Bernd Auber(Medizinische Hochschule Hannover), Karen A. Pooley(University of Cambridge), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Hugues Aschard(Harvard University), Laura Fachal(University of Cambridge), Daniel Barrowdale(University of Cambridge), Jamie Allen(University of Cambridge), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Aðalgeir Arason(University of Iceland), Irene L. Andrulis(University of Toronto), Katarzyna Białkowska(International Hereditary Cancer Center), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Constance Turman(Harvard University), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carl Blomqvist(University of Helsinki), Rósa B. Barkardóttir(University of Iceland), Maya Ghoussaini(Regeneron (United States)), Siddhartha Kar(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Judith Balmañà(Vall d'Hebron Hospital Universitari), Audrey Lemaçon(University of Cambridge), Kristan J. Aronson(Queen's University), Simona Agata(Roswell Park Comprehensive Cancer Center), Alicia Beeghly‐Fadiel(University of Helsinki), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Kristiina Aittomäki(University of Helsinki), M. Rosario Alonso(Spanish National Cancer Research Centre), Penny Soucy(University of Cambridge), Manjeet K. Bolla(University of Cambridge), Marina Bermisheva(Russian Academy of Sciences), Jonathan Beesley(QIMR Berghofer Medical Research Institute)
Cited by 189
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k